ICUIICU Medical, Inc.

$3B

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$319M+3.6% YoY

Gross Profit

$114M35.8% margin

Operating Income

$26M8.0% margin

Net Income

$25M7.8% margin

EPS (Diluted)

$1.16

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

$75M

Free Cash Flow

$56M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$277M

Stockholders' Equity

$1.5B

Cash & Equivalents

$351M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$319M	$307M	+3.6%
Gross Profit	$114M	$119M	-3.9%
Operating Income	$26M	$33M	-22.4%
Net Income	$25M	$27M	-5.9%

Revenue Segments

Infusion Consumables

$116M36%

IV Solutions

$102M32%

Infusion Systems

$88M28%

Critical Care

$12M4%

Geographic Segments

UNITED STATES

$237M75%

Other foreign countries

$49M15%

EMEA

$33M10%

ICUI Q3 2020 Earnings — ICU Medical, Inc. Revenue & Financial Results | Market Cap Arena